Skip to main content
. Author manuscript; available in PMC: 2012 Sep 10.
Published in final edited form as: J Pharm Biomed Anal. 2011 Jun 6;56(2):390–401. doi: 10.1016/j.jpba.2011.05.039

Figure 3.

Figure 3

Figure 3

Panel A. Extracted clinical research sample for TFV Centric Mode of analysis for hPBMC-TP. This sample had a TFV-DP of 44.8 fmol/10^6 Cells and FTC-TP of 6.20 pmol/10^6 cells. Panel B. Extracted clinical research sample for ZDV Centric Mode of analysis for hPBMC-TP. This sample had a ZDV-TP of 64.5 fmol/10^6 Cells and 3TC-TP of 8.80 pmol/10^6 cells.